Improving Glycemic Control in Adults and Children with Type 1 Diabetes with the Use of Smart-Phone Based Mobile Applications: a Systematic Review

The objectives of this study were to examine the literature evaluating the use of mobile apps (stand-alone and text messaging/feedback) in T1DM, and to review top-rated mobile apps applicable to T1DM.MethodsMedline, Cochrane and Embase databases were systematically searched to identify studies published from inception to February 2018. Top-rated relevant apps from Google Play Store and Apple App Store were reviewed in July, 2017.ResultsThe literature search yielded 3462 studies. Nine studies evaluated the stand-alone apps. Three showed significant improvement in HbA1C (0.5%, p
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research

Related Links:

Publication date: Available online 2 June 2020Source: Canadian Journal of DiabetesAuthor(s): Sheri R. Colberg
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Have type 1 diabetes and being forced to work during the pandemic? Here are the legal resources to know about.
Source: Diabetes Mine - Category: Endocrinology Authors: Source Type: blogs
Abstract The extract of Lycium bark (LBE), which is the root bark of Lycium chinense, has long been used in China for hypertension, inflammation, and diabetes. LBE has been reported to ameliorate hyperglycemia in mice with alloxan-induced type 1 diabetes, but evidence on the effect of LBE in diabetes had not been enough. Therefore, we investigated the effects of LBE on type 2 diabetes using db/db mice. Nine-week-old male db/db mice were orally administered LBE (425 mg/kg) for 10 weeks. Blood samples were collected under anesthesia for the determination of blood glucose and insulin levels. The blood glucose ...
Source: Biological and Pharmaceutical Bulletin - Category: Drugs & Pharmacology Authors: Tags: Biol Pharm Bull Source Type: research
We describe a unique, complex case of a man resulted affected by both APS-2 and MEN-2a. The patient developed Hashimoto's thyroiditis, diabetes mellitus type 1 and AAD, despite testing negative for adrenal cortex autoantibodies (ACA) and steroid 21-hydroxylase autoantibodies (21-OHAb). Moreover, he had also a family history for MEN-2a and he first developed medullay thyroid cancer, then bilateral pheochromocytoma on the adrenal substrate of an AAD. On adrenal histology we found complete bilateral cortical atrophy in the presence of a lymphocytic infiltration and fibrosis, confirming an ACA and 21-OHAb-negative AAD. This da...
Source: Endocrine Journal - Category: Endocrinology Tags: Endocr J Source Type: research
Out-of-pocket costs for Americans with type 1 diabetes average $2,500 a year, a new study says.
Source: WebMD Health - Category: Consumer Health News Source Type: news
Condition:   T1DM Interventions:   Device: Hyperbaric oxygen chamber (HBOC);   Device: sham Hyperbaric oxygen chamber (HBOC) Sponsor:   Assaf Harofeh MC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
TUESDAY, June 2, 2020 -- Out-of-pocket costs for Americans with type 1 diabetes average $2,500 a year, a new study says. But 8% of patients have more than $5,000 in out-of-pocket costs, possibly due to having high-deductible health insurance plans...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
ConclusionsHHS/DKA occurred mostly in T1D and younger patients. However, both also occurred in T2D, which is of great importance in the treatment of diabetes. Better education programmes are necessary to prevent decompensation and comorbidities.
Source: Acta Diabetologica - Category: Endocrinology Source Type: research
Conclusions: Allogenic ASCs + cholecalciferol without immunosuppression was associated with stability of CP and unanticipated mild transient adverse events in patients with recent onset T1D.ClinicalTrials.gov registration: NCT03920397.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
The number of diabetic patients in Europe and world-wide is growing. Diabetes confers a 2-fold higher risk for vascular disease. Lack of insulin production (Type 1 diabetes, T1D) or lack of insulin responsiveness (Type 2 diabetes, T2D) causes systemic metabolic changes such as hyperglycemia (HG) which contribute to the pathology of diabetes. Monocytes and macrophages are key innate immune cells that control inflammatory reactions associated with diabetic vascular complications. Inflammatory programming of macrophages is regulated and maintained by epigenetic mechanisms, in particular histone modifications. The aim of our s...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Canada Health | Children | Databases & Libraries | Diabetes | Diabetes Type 1 | Endocrinology | Study